This report is a summary of data on device-associated infections (DAI) within intensive care units (ICUs) collected by hospitals participating in the International Nosocomial Infection Control Consortium (INICC; Appendix) 1 between January 2002 and December 2007. The INICC is an international, nonprofit, open, multicenter, collaborative health care-associated infection control program with a surveillance system based on that of the US National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]). 1 Founded in Argentina in 1998, the INICC is the first multinational research network established to control and reduce DAI through the analysis of data collected on a voluntary basis by a pool of hospitals worldwide. The INICC has the following goals: create a dynamic global network of hospitals in the world that conducts surveillance of health care-associated infections (HAIs) using standardized definitions and established methodologies, promote implementation of evidence-based infection control practices, and carry out applied infection control research; provide training and surveillance tools to individual hospitals that can allow them to conduct outcome and process surveillance of HAIs, measure their consequences, and assess the impact of infection control practices; to improve the safety and quality of health care worldwide through implementation of systematized programs to reduce rates of HAI, associated mortality, excess lengths of stay, excess costs, and bacterial resistance.
METHODS
The INICC at this time has focused on surveillance and prevention of DAI in adult and pediatric ICUs and high-risk nurseries. 1 The data are collected using standardized Centers for Disease Control and Prevention (CDC) NNIS protocols and definitions. [2] [3] [4] The INICC has both outcome surveillance and process surveillance components. The modules of the components may be used singly or simultaneously, but, once selected, they must be used for a minimum of 1 calendar month.
All DAIs of the outcome surveillance component are categorized using standard CDC NNIS definitions that include laboratory and clinical criteria. Both laboratory-confirmed bloodstream infections (BSIs) and clinical sepsis without microbiologic confirmation of BSI are recorded and reported. 3 Within the outcome surveillance component, data are classified into specific module protocols addressing the following: DAI rates, excess length of stay, evaluation of HAI costs, crude excess mortality, microbiologic profile, bacterial resistance, and antimicrobial use data. In addition, INICC methodology includes a process for adjudication of and validation of reported HAIs. 1 Infection control professionals (ICPs) collect data on central line-associated primary bloodstream infections (CLABs), catheter-associated urinary tract infections (CAUTIs), and ventilator-associated pneumonias (VAPs) occurring in patients hospitalized in an ICU. ICUs are stratified according to the patient population: adult, pediatric, or neonatal units (NICUs).
All NICUs are level III or level II/III units, and ICPs collect data on CLABs and umbilical catheter-associated primary BSIs or VAPs for each of 5 birth-weight categories (,750 g, 750-1000 g, 1001-1500 g, 1501-2500 g, .2500 g). Corresponding denominator data, patientdays, and specific device-days are also collected.
The process surveillance component includes the following modules: hand hygiene compliance monitoring in ICUs; central and peripheral vascular catheter care compliance monitoring; urinary catheter care compliance monitoring; monitoring of compliance with measures to prevent VAP; and performance feedback. Data from the process surveillance module on hand hygiene compliance are included in this report. The identity of all INICC hospitals, cities, and countries is confidential, in accordance with the INICC charter.
RESULTS
Characteristics of 98 ICUs from 18 countries in Latin America, Asia, Africa, and Europe currently participating in the INICC that contributed data for this report are shown in Table 1 . The participation of hospitals in the INICC program is as follows: mean length of participation 6 SD, 15.9 6 14.3 months, range 1 to 70 months; 10th percentile, 1 month; 25th percentile, 5 months; 50th percentile, 12 months; 75th percentile, 21 months; 90th percentile, 70 months.
For the outcome surveillance component, DAI rates, device utilization (DU) ratios, crude excess mortality by specific type of DAI, antimicrobial utilization, and bacterial resistance for January 2002 through December 2007 are summarized (Tables 2-10).  Tables 2, 3 , and 4 show DAI rates and DU ratios by infection type (CLAB, CAUTI, VAP, respectively) in adult and pediatric ICUs. Inclusion in these Tables required data from at least 5 ICUs of a given type. The data for adult combined medical/surgical ICUs were not stratified by type or size of hospital. Device-days consisted of the total number of central line-days, urinary catheter-days, or ventilator-days. The DU ratio constitutes an extrinsic risk factor for HAI. 5 DU also comprises a marker for severity of illness of patients, vis-a-vis patients' susceptibility to HAI. Tables 5 and 6 show DAI rates and DU ratios from the high-risk nursery component of the INICC system for CLABs and VAPs. For NICUs, device-days consist of the total number of central line-days, umbilical catheter-days, and ventilator-days. Table 7 provides data on crude ICU mortality in patients hospitalized in each type of unit during the surveillance period with and without DAI and crude excess mortality of adult and pediatric patients with CLAB, CAUTI, and VAP and infants in NICUs with CLAB or VAP. Table 8 provides data on antimicrobial utilization in the INICC ICUs. Table 9 provides data on bacterial resistance of pathogens isolated from patients with DAI in adult and pediatric ICUs and NICUs. Table  10 provides data on hand hygiene compliance before patient contacts in the consortium ICUs. Tables 11  and 12 compare rates of CLAB, CAUTI, and VAP (Table 11 ) 
DISCUSSION
Studies done in US hospitals 30 years ago showed that an integrated infection control program that includes surveillance of HAIs can reduce the incidence of infections by as much as 30% and can lead to reduced health care costs. 6 Inspired by the success of the CDC's long-standing NNIS/NHSN network, which has provided invaluable benchmarking data on DAIs and antimicrobial resistance in US hospital ICUs for more than 30 years, 5,7-10 we chose to focus the INICC's first effort on surveillance of DAI in the ICU 1 because it addresses the health care setting with the most vulnerable patients and the heaviest exposure to invasive devices and highest rates of HAI.
Although device use in the consortium ICUs is similar or slightly lower than that reported from US ICUs in the NHSN system 10 we found that INICC rates of DAI are far higher (Table 11) . Moreover, the proportions of Staphylococcus aureus isolates resistant to methicillin (MRSA), Enterobacteriaceae resistant to ceftriaxone, and Pseudomonas aeruginosa resistant to fluoroquinolones were also much higher in the consortium ICUs than in the NNIS ICUs (Table 12 ); in contrast, the proportion of enterococcal isolates resistant to vancomycin was considerably lower in the INICC ICUs.
The higher rates of DAI that appear to be representative of ICUs in developing countries 1, [11] [12] [13] [14] [15] [16] [17] have many plausible explanations. Some have been previously mentioned in prior published reports from developing countries. 18 First, it has to be taken into account that most developing countries lack any legal framework or laws governing the establishment of infection control programs. Nevertheless, in the limited cases where such regulations exist, for example, in the form of national infection control guidelines, compliance is usually variable, at best. Moreover, hospital accreditation is not compulsory. Second, hand hygiene compliance in most health care facilities is also highly variable. Third, the great majority of hospitals in the developing countries receives limited financial or administrative support, which invariably results in very limited funds for infection control. 18, 19 Fourth, nurse-to-patient staffing ratios in hospitals in developing countries are typically very low, as compared with hospitals in the developed countries; low nurse-to-patient staffing ratios have been shown to be powerful determinants of high DAI rates in ICUs. 20 These problems are compounded by overcrowding in most hospitals, few experienced nurses, and pressing shortages of other trained health care personnel and supplies.
Surveillance of HAIs-defining the magnitude and nature of the problem-is the first step toward reducing the risk of infection in vulnerable hospitalized patients. The next step is to implement targeted basic infection control practices that have been shown to prevent HAIs. Increased awareness of the risks of DAI in the Consortium ICUs, which has been enormously enhanced by participation in the INICC, 1 is providing the impetus for instituting positive change: targeted performance feedback programs for hand hygiene and CVC, ventilator, and urinary catheter care have already reduced the incidence of ICU-acquired infections in many consortium hospitals. [21] [22] [23] [24] [25] Control of antibiotic resistance will mandate effective nosocomial infection control and more restrictive use of antiinfectives. 26 If hospitals wish to compare their hospital's rates of HAI and DU ratios with those in this report, they must first collect information from their hospital in accordance with the methods described for the CDC NNIS and the INICC. [1] [2] [3] [11] [12] [13] [14] [15] [16] [17] They should calculate infection rates and DU ratios for the device-associated module. Regarding interpretation of percentiles of infection rates or DU ratios, a high rate or ratio (.90th percentile) does not necessarily define a problem but suggests an area for further investigation. Similarly, a low rate or ratio (,10th percentile) may be the result of suboptimal surveillance. Hospitals should use these data to guide local prevention strategies and other quality improvement efforts aimed at reducing HAI rates as much as possible.
In summary, these data reaffirm that HAIs, especially DAIs in ICU patients, are a huge and largely unrecognized threat to patient safety in the developing world, a far greater threat than in the developed countries. We hope that the activities of the INICC, with efforts to implement simple and inexpensive measures for prevention far more consistently, will lead to wider acceptance of infection control practices and material reductions in DAIs, not only in the member hospitals of the Consortium but in the innumerable other hospitals of the developing world. 
